2022

1. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy

   Cancers, Vol. 14, Núm. 1

2. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

   Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24

3. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

   Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734